aTyr Pharma ATYR Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $10.01M-6.8% | $10.74M+74.7% | $6.15M-64.3% | $17.22M+66.2% | $10.36M-6.3% | ||
| $56.51M-16.8% | $67.94M-19.2% | $84.05M+33.1% | $63.13M-4.3% | $65.99M+8.1% | ||
| $1.81M-19.2% | $2.24M-17.6% | $2.71M-5.8% | $2.88M+18.3% | $2.43M-17.6% | ||
| $586K-13.4% | $677K-61.8% | $1.77M-73.4% | $6.65M+12.0% | $5.93M-26.7% | ||
| $67.58M-15.8% | $80.24M-13.7% | $93.01M+6.3% | $87.49M+5.1% | $83.27M+1.6% | ||
| $4.24M-0.6% | $4.26M-3.7% | $4.43M-2.1% | $4.53M-3.4% | $4.68M-3.4% | ||
| $5.44M-1.5% | $5.52M-1.4% | $5.6M-1.3% | $5.68M-1.3% | $5.75M-1.2% | ||
| $148K0.0% | $148K-0.7% | $149K+126% | $66K0.0% | $66K0.0% | ||
| $79.65M-14.4% | $93M-12.8% | $106.65M+5.0% | $101.53M+4.4% | $97.25M+0.4% | ||
| $2.76M-29.2% | $3.89M-4.3% | $4.06M+4.7% | $3.88M+153% | $1.53M-64.6% | ||
| $7.46M-23.8% | $9.79M-3.9% | $10.19M-1.3% | $10.32M+31.3% | $7.86M-16.3% | ||
| $596K-5.4% | $630K0.0% | $630K+12.1% | $562K+2.2% | $550K+1.7% | ||
| $890K+6.5% | $836K+4.6% | $799K+3.9% | $769K+3.9% | $740K+4.1% | ||
| $596K-5.4% | $630K0.0% | $630K+12.1% | $562K+2.2% | $550K+1.7% | ||
| $11.7M-22.8% | $15.15M-3.4% | $15.68M+0.9% | $15.53M+45.4% | $10.68M-28.6% | ||
| $10.06M-2.4% | $10.31M-2.1% | $10.53M-2.0% | $10.75M-1.9% | $10.95M-1.7% | ||
| $747K-16.0% | $889K-13.5% | $1.03M-11.7% | $1.16M-10.3% | $1.3M-9.2% | ||
| $10.95M-1.7% | $11.14M-1.7% | $11.33M-1.6% | $11.51M-1.5% | $11.69M-1.4% | ||
| $151K-41.7% | $259K-34.9% | $398K-33.9% | $602K-19.4% | $747K-15.8% | ||
| —— | —— | —— | —— | —— | ||
| $98K0.0% | $98K0.0% | $98K+5.4% | $93K+4.5% | $89K+6.0% | ||
| $674.86M+0.2% | $673.55M+0.2% | $672.34M+4.8% | $641.28M+3.1% | $621.95M+3.3% | ||
| -$616.96M-1.8% | -$606.16M-2.4% | -$592.2M-4.5% | -$566.46M-3.6% | -$546.93M-2.8% | ||
| -$70K-775% | -$8K-700% | -$1K+98.7% | -$75K-13.6% | -$66K-65.0% | ||
| -$193K-0.5% | -$192K-0.5% | -$191K-1.1% | -$189K-0.5% | -$188K-0.5% | ||
| $57.93M-14.1% | $67.48M-15.9% | $80.24M+7.2% | $74.85M-0.3% | $75.05M+7.2% | ||
| $79.65M-14.4% | $93M-12.8% | $106.65M+5.0% | $101.53M+4.4% | $97.25M+0.4% | ||
| $56.51M-16.8% | $67.94M-19.2% | $84.05M+33.1% | $63.13M-4.3% | $65.99M+8.1% | ||
| $477K-45.4% | $873K-16.2% | $1.04M+109% | $498K-49.6% | $988K-43.1% | ||
| $477K-45.4% | $873K-16.2% | $1.04M+109% | $498K-49.6% | $988K-43.1% | ||
| $148K0.0% | $148K-0.7% | $149K+126% | $66K0.0% | $66K0.0% | ||
| $5.44M-1.5% | $5.52M-1.4% | $5.6M-1.3% | $5.68M-1.3% | $5.75M-1.2% | ||
| $5.44M-1.5% | $5.52M-1.4% | $5.6M-1.3% | $5.68M-1.3% | $5.75M-1.2% | ||
| $148K0.0% | $148K-0.7% | $149K+126% | $66K0.0% | $66K0.0% | ||
| $5.44M-1.5% | $5.52M-1.4% | $5.6M-1.3% | $5.68M-1.3% | $5.75M-1.2% | ||
| $148K0.0% | $148K-0.7% | $149K+126% | $66K0.0% | $66K0.0% | ||
| $7.46M-23.8% | $9.79M-3.9% | $10.19M-1.3% | $10.32M+31.3% | $7.86M-16.3% | ||
| $7.46M-23.8% | $9.79M-3.9% | $10.19M-1.3% | $10.32M+31.3% | $7.86M-16.3% | ||
| $12.3M-2.9% | $12.66M-2.5% | $12.99M-1.9% | $13.24M-2.2% | $13.54M-2.1% | ||
| $98K0.0% | $98K0.0% | $98K+5.4% | $93K+4.5% | $89K+6.0% | ||
| $596K-5.4% | $630K0.0% | $630K+12.1% | $562K+2.2% | $550K+1.7% | ||
| $447K-25.0% | $596K-20.0% | $745K-16.7% | $894K-14.3% | $1.04M-12.5% | ||
| -$193K-0.5% | -$192K-0.5% | -$191K-1.1% | -$189K-0.5% | -$188K-0.5% | ||
| $586K-13.4% | $677K-61.8% | $1.77M-73.4% | $6.65M+12.0% | $5.93M-26.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are aTyr Pharma's total assets?
- aTyr Pharma (ATYR) holds $79.7M in total assets, down 18.1% year over year.
- How much debt does aTyr Pharma have?
- aTyr Pharma carries $12.3M in total debt against $57.9M of shareholders' equity, a debt-to-equity ratio of 0.21.
- How much cash does aTyr Pharma have?
- aTyr Pharma holds $10.0M in cash and equivalents.
- Can aTyr Pharma cover its short-term obligations?
- Its current ratio is 5.78 — current assets exceed current liabilities.
- Where does aTyr Pharma's balance sheet data come from?
- Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
